Singapore vs Tonga: Cause of death, by non-communicable diseases, ages 15-59
Singapore
80.7%
in 2021
Tonga
80.1%
in 2021
Singapore rank
2nd
Tonga rank
4th
Cause of death, by non-communicable diseases, ages 15-59 over time
- Singapore
- Tonga
How they compare
Singapore currently reports 80.7% against 80.1% in Tonga, a difference of 0.6%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Tonga ahead.
Singapore ranks 2nd and Tonga ranks 4th of 185 countries.
Across the 3 decades both report, Singapore averaged higher in 2 and Tonga in 1.
Head to head by decade
| Decade | Singapore | Tonga | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 73.3% | 74.8% | 1.4% | Tonga |
| 2010s | 78.0% | 77.8% | 0.2% | Singapore |
| 2020s | 80.3% | 79.5% | 0.8% | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, Singapore or Tonga?
- Singapore, at 80.7% against 80.1% in Tonga as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59 between Singapore and Tonga?
- 0.6%, with Singapore ahead.
- How many years of comparable data are there for Singapore and Tonga?
- 6 years are reported by both, from 2000 to 2021.
- How do Singapore and Tonga rank globally for cause of death, by non-communicable diseases, ages 15-59?
- Singapore ranks 2nd and Tonga ranks 4th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.